The Board has approved the app of Mr. Sanjay Patel, as an Independent director, Re app of Mr. Rajendra R Shah as a MD and cessation of Mr. Bharat Mehta
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mercury Laboratories' board met on May 14, 2025 and approved audited FY25 results with an unmodified auditor opinion. FY25 revenue from operations was Rs 7,510.12 lakhs (slightly down from Rs 7,555.90 lakhs in FY24), while net profit dropped 44% to Rs 314.49 lakhs (from Rs 565.42 lakhs); Q4 FY25 net profit was Rs 111.04 lakhs vs Rs 191.03 lakhs last year. The board recommended a final dividend of Rs 3.50 per share (35%) for FY25. On the board front, Sanjay Patel was appointed as a Non-Executive Independent Director and Chairman, Rajendra R Shah was re-appointed as Managing Director for three years from April 1, 2026, and Independent Director Bharat Mehta stepped down after completing his second term. Various auditors were also re-appointed.
Shareholders get a stable 35% dividend (Rs 3.50/share) despite a sharp profit fall, which signals confidence in cash flows but the weak FY25 earnings could cap near-term upside. Continuity in leadership (MD re-appointed) and a new Independent Chairman provide governance stability ahead of the August 13 AGM.